IDEXX Laboratories Inc
IDXX- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000874716
In the last 90 days, IDEXX Laboratories Inc insiders filed 0 open-market purchases and 1 sale; 1,306 institutions reported holding it in 13F filings for Q2 2026, worth $39.1B in total; 3 superinvestors hold it, including Fundsmith and Weitz Investment Management.
Q2 2021 vs. Q1 2021
How the institutions holding IDEXX Laboratories Inc changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Of which not filed for Q2 2021 | Q2 2021 | Change |
|---|---|---|---|---|
| Holders | 1,015 | 13 | 1,037 | +35 |
| Shares | 72.7M | 363.8K | 73.0M | +695.7K (+1.0%) |
| Value | $35.6B | $178.0M | $46.1B | +$10.7B (+30.2%) |
13 institutions that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (108)
Institutions that held IDEXX Laboratories Inc at the end of Q2 2021 but not at the end of Q1 2021.
Showing the largest 100 of 108 by value.
Sold out (73)
Institutions that held IDEXX Laboratories Inc at the end of Q1 2021 and filed for Q2 2021 without it.
Not filed for Q2 2021 yet (13)
Institutions that held IDEXX Laboratories Inc at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Amundi Asset Management US, Inc. | 341,404 | $167.1M |
| Bokf, NA | 12,629 | $6.18M |
| BBVA USA Bancshares, Inc. | 3,003 | $1.47M |
| E Fund Management Co., Ltd. | 1,200 | $587.0K |
| Money Concepts Capital Corp | 1,063 | $520.0K |
| Camden National Bank | 1,055 | $516.0K |
| North American Management Corp | 1,050 | $513.8K |
| OneAscent Wealth Management LLC | 848 | $415.0K |
| First National Bank | 673 | $329.0K |
| WealthStone, Inc. | 526 | $257.0K |
| Tompkins Financial Corp | 261 | $128.0K |
| New Capital Management LP | 100 | $49.0K |
| CSat Investment Advisory, L.P. | 37 | $18.0K |